Medication info
Telmisartan 80 mg Tablets

Telmisartan 80 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
Il Sung I.S. Co., Ltd.
Appearance
White or whitish oval tablets
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201209648 · Approved 2012.12.13 · Insurance code 655403020

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular diseases
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily with water, and it may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. After starting treatment, the maximum blood pressure-lowering effect is achieved within 4 ∼ 8 weeks when the dose is increased. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Il Sung I.S. Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular diseases

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • and clinical evidence of end-organ damage from high-risk diabetes.
View approved original text

This medication is used to reduce blood pressure in patients with essential hypertension. Additionally, it helps reduce the risk of myocardial infarction, stroke, and death from cardiovascular disease in patients aged 55 and older with a history of coronary artery disease, peripheral artery disease, stroke, or transient ischemic attack, or with clinical evidence of end-organ damage from high-risk diabetes. It is particularly offered as an alternative for patients who cannot use ACE inhibitors and is effective in reducing the overall risk of cardiovascular disease. Therefore, this medication is used for the management of hypertension as well as maintaining cardiovascular health.

How to take

Adult dose

1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily with water, and it may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. After starting treatment, the maximum blood pressure-lowering effect is achieved within 4 ∼ 8 weeks when the dose is increased. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergic reactions to this medication or a history of severe liver impairment, bile duct obstruction, or hereditary angioedema should not use it. Certain patient groups such as the elderly, patients with hyperkalemia, and those with mild to moderate liver impairment should use it with caution, especially if there are underlying heart or kidney diseases. Regular monitoring of blood pressure and kidney function is necessary as blood pressure may become too low or kidney function may decline during treatment with this medication. Care should be taken when consuming potassium-rich foods or potassium supplements as there is an increased risk of elevated potassium levels in the blood. This medication may interact when used with other antihypertensives or specific drugs, so all current medications should be disclosed to healthcare providers and regular monitoring may be needed. Caution is advised during driving or operating machinery as dizziness or fainting may occur. Use of this medication is not recommended for children, pregnant women, or breastfeeding women. In case of an overdose, hypotension, dizziness, or acute renal failure may occur, and immediate medical assistance should be sought. This medication should be stored out of reach of children, and it is advisable to open the sealed package just prior to use.

Side effects

  • Upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 126 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • vertigo
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbance
  • abnormal liver function
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • fatigue
  • appetite loss
  • cold sweat
  • tremor
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • fever
  • pneumonia
  • myalgia
  • increased creatine kinase
  • elevated myoglobin in serum
  • elevated myoglobin in urine
  • palpitations
  • fatigue
  • nausea
  • insufficient effect
  • headache
  • dizziness
  • cough
  • dyspepsia
  • palpitations
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • appetite loss
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial swelling
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • dyspepsia
  • cough
  • abdominal pain
  • appetite loss
  • weakness
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea
  • hypotension
  • tachycardia
  • bradycardia
  • dizziness
  • acute renal failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture and kept at room temperature between 1°C and 30°C. This storage method helps maintain the drug's efficacy and safety.

Appearance and packaging

Appearance

White or whitish oval tablets

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.